Twareat Medical Care Company SCJSC

Twareat Medical Care Company SCJSC has a liquidity risk profile marked by a current ratio of 1.44, indicating that its current assets slightly exceed its current liabilities, but the margin is narrow. The company's liquidity position is further constrained by a negative free cash flow of -27.85 million SAR, driven by capital expenditures of -12.75 million SAR. This suggests that the company is investing heavily in its operations, which could be a strategic move to expand its healthcare infrastructure. Profitability metrics show a challenging performance, with a return on equity of -22.13% and a return on assets of -9.56%. These figures indicate that the company is not generating returns that meet the cost of equity or assets, which is below the industry median for healthcare facilities and services. The operating loss of 7.08 million SAR and a net loss of 10.32 million SAR further underscore the company's financial difficulties. The company's geographic and segment exposure is concentrated in Saudi Arabia, with a focus on corporate and individual healthcare services. Its operations span a wide range of healthcare facilities, including clinics, hospitals, and mobile medical units. However, the company's revenue concentration in a single country and sector increases its vulnerability to local economic and regulatory changes. Growth trajectory is mixed, with the company investing in capital expenditures but reporting a net loss. The outlook for the current fiscal year is uncertain, with no clear indication of revenue growth. The company's debt-to-equity ratio of 0.69 suggests a moderate level of leverage, but the negative free cash flow and operating cash flow indicate that the company may need to seek additional financing to sustain its operations. Risk factors include liquidity constraints and the potential for dilution, although the risk of dilution is currently assessed as low. The company's debt structure, with long-term debt of 32.35 million SAR, and the negative free cash flow pose a risk to its financial stability. The risk assessment highlights the need for the company to improve its cash flow generation to support its capital-intensive operations. Recent events include the company's continued investment in healthcare infrastructure, as evidenced by the capital expenditures. The company's 10-K filing also notes the importance of maintaining a strong liquidity position to support its operations. However, the financial results for the latest period show a net loss, which may impact investor confidence.